Literature DB >> 6330549

Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.

R M Carey, S Sen, L M Dolan, C D Malchoff, F M Bumpus.   

Abstract

To test the hypothesis that idiopathic hyperaldosteronism is secondary to increased adrenal stimulation by aldosterone-stimulating factor, we measured the latter in seven patients with idiopathic hyperaldosteronism and in four patients who had undergone surgical removal of an aldosterone-producing adenoma. In the patients with hyperaldosteronism, plasma aldosterone concentrations (mean +/- 1 S.E.) were 38 +/- 10 and 78 +/- 19 ng per deciliter in the supine and upright position, respectively (P less than 0.01). Supine plasma aldosterone-stimulating factor was 81 +/- 5 ng per deciliter in 15 normal subjects and 185 +/- 10 (P less than 0.01) in the patients with idiopathic hyperaldosteronism. After removal of an aldosterone-producing adenoma, plasma aldosterone-stimulating factor was normal. The supine value in each patient with idiopathic hyperaldosteronism was above the normal range (61 to 91 ng per deciliter) and increased to 290 +/- 59 ng per deciliter after four hours of upright posture. Twenty-four hour urinary excretion of aldosterone-stimulating factor was 424 +/- 35 ng (normal, 145 +/- 3; P less than 0.01) by affinity chromatography and high-pressure liquid chromatography, and it was not suppressed after two days of treatment with dexamethasone (0.5 mg orally every six hours). At the end of 48 hours, plasma concentrations were 248 +/- 40 ng per deciliter. Plasma cortisol and ACTH concentrations were under 2 micrograms per deciliter and under 40 pg per milliliter, respectively. We conclude that increased secretion of aldosterone-stimulating factor may be the cause of idiopathic hyperaldosteronism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330549     DOI: 10.1056/NEJM198407123110205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  5 in total

Review 1.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

2.  Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

Authors:  G T Griffing; B Berelowitz; M Hudson; R Salzman; J A Manson; S Aurrechia; J C Melby; R C Pedersen; A C Brownie
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Lack of prolactin involvement in corticosteroid secretion.

Authors:  J N Hugues; E Modigliani; F Girard; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

4.  Central serotonergic stimulation of aldosterone secretion.

Authors:  Y Shenker; M D Gross; R J Grekin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.

Authors:  M Stimpel; K Ivens; H P Volkmann; G Wambach; W Kaufmann
Journal:  Klin Wochenschr       Date:  1989-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.